Squarepoint’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-43,886
Closed -$506K 2587
2018
Q4
$506K Buy
43,886
+22,651
+107% +$302K 0.01% 1238
2018
Q3
$434K Buy
+21,235
New +$436K 0.01% 1369

Other funds holding NITE

Squarepoint's NITE Position: Q1 2019 in Review

Squarepoint sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 43,886 shares — an estimated $506K sold.

Squarepoint first reported a position in NITE in Q3 2018 and held it in 2 quarters. The position peaked at $506K in Q4 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

  • Squarepoint reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Squarepoint sold 43,886 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $506K.
  • Squarepoint first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2018 and held it in 2 quarters.
  • Squarepoint's Nightstar Therapeutics plc American Depositary Shares position peaked at $506K in Q4 2018.
  • 53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Squarepoint's 13F filing for Q1 2019, filed 15 May 2019.